Verve, Africa’s leading domestic payments card scheme and token brand and a subsidiary of the Interswitch Group, has been named in the Global Payments Power 50 list by The Power 50. According to ...

Verve Therapeutics (NASDAQ:VERV) just today announced that it had received IND clearance from the FDA in the United States in order to advance its 2nd gene editing candidate VERVE-102 for the ...

PalmPay, one of Africa’s fastest-growing fintech platforms, today officially launched its new PalmPay Debit Card in partnership with Verve, Africa’s largest domestic card scheme. This ...

Verve International’s Managing Director, Vincent Ogbunude, highlighted the significance of the partnership in broadening financial access. He said, “We are proud to partner with PalmPay on ...

Verve Therapeutics is expanding a gene editing trial for a cholesterol and heart disease treatment into the U.S., the company said Monday after receiving clearance from the Food and Drug ...

One of Nigeria’s fastest-growing fintech companies, PalmPay, has unveiled its debit card in partnership with Verve, a local card issuer The unveiling of PalmPay’s debit card comes amid the clamour by ...